Bizarre Patents
Combination Beverage Container and Spittoon
A combination beverage container and spittoon includes a bottom portion including outer wall and a first inner wall defining a spittoon space.
PatentStorm News
Make the Most of PatentStorm
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest patents by subscribing to an RSS feed.
Got questions? Ask a Patent Expert!
Registered users: Manage your profile, comments and alerts.
US Patent 6143728 - Guanylhydrazones useful for treating diseases associated with T cell activation
US Patent Issued on November 7, 2000
Estimated Patent Expiration Date:
November 14, 2017Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Estimated Patent Expiration Date:
November 14, 2017Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.AbstractThere is disclosed a method for treating diseases and disorders involving T cell activation and HIV-infection, using the p38 mitogen activated protein kinase (MAPK) signaling pathway as a target for intervention. There is further disclosed a use for guanylhydrazone-substituted compounds to treat diseases and disorders related to T cell activation and HIV-infection. | InventorsAssigneeApplicationNo. 970973 filed on 11/14/1997US Classes:514/44, Polynucleotide (e.g., RNA, DNA, etc.)435/6, Involving nucleic acid514/1, DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI)514/597, Benzene ring is part of a substituent which contains nitrogen514/614, N-N containing (e.g., aminimine, hydrazine, etc.)514/615, R contains benzene ring514/616, Plural carboxamide groups or plural C=O groups bonded directly to the same nitrogen514/632, Amidino hydrazines or hydrazones (i.e., N-N=C-N or N=C-N-N)536/22.1N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.)Field of Search435/6, Involving nucleic acid536/22.1, N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.)514/1, DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI)514/597, Benzene ring is part of a substituent which contains nitrogen514/44, Polynucleotide (e.g., RNA, DNA, etc.)514/614, N-N containing (e.g., aminimine, hydrazine, etc.)514/615, R contains benzene ring514/616, Plural carboxamide groups or plural C=O groups bonded directly to the same nitrogen514/632Amidino hydrazines or hydrazones (i.e., N-N=C-N or N=C-N-N)ExaminersPrimary: Riley, JeziaAttorney, Agent or FirmUS Patent References5837737, Hydrazinedicarboximidamide compounds and pharmaceutical composition comprising sameIssued on: 11/17/1998 Inventor: Goldin, et al.5854289Guanylhydrazones and their use to treat inflammatory conditions Issued on: 12/29/1998 Inventor: Bianchi, et al. International ClassesA01N 043/04A01N 047/28 C12Q 001/68 C07H 019/00 |
